Medartis Holding AG
SIX:MED

Watchlist Manager
Medartis Holding AG Logo
Medartis Holding AG
SIX:MED
Watchlist
Price: 88.8 CHF 1.49% Market Closed
Market Cap: 1.2B CHF

Medartis Holding AG
Total Equity

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Medartis Holding AG
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Medartis Holding AG
SIX:MED
Total Equity
CHf261.2m
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Alcon AG
SIX:ALC
Total Equity
$22.1B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Coltene Holding AG
SIX:CLTN
Total Equity
CHf90.4m
CAGR 3-Years
-4%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
Total Equity
CHf807.2m
CAGR 3-Years
17%
CAGR 5-Years
16%
CAGR 10-Years
12%
IVF Hartmann Holding AG
SIX:VBSN
Total Equity
CHf145.4m
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
6%
No Stocks Found

Medartis Holding AG
Glance View

Market Cap
1.1B CHF
Industry
Health Care

Medartis Holding AG operates as a medical device company. The company is headquartered in Basel, Basel-Stadt and currently employs 684 full-time employees. The company went IPO on 2018-03-23. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. The company has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.

MED Intrinsic Value
93.32 CHF
Undervaluation 5%
Intrinsic Value
Price

See Also

What is Medartis Holding AG's Total Equity?
Total Equity
261.2m CHF

Based on the financial report for Jun 30, 2025, Medartis Holding AG's Total Equity amounts to 261.2m CHF.

What is Medartis Holding AG's Total Equity growth rate?
Total Equity CAGR 5Y
5%

Over the last year, the Total Equity growth was -4%. The average annual Total Equity growth rates for Medartis Holding AG have been 2% over the past three years , 5% over the past five years .

Back to Top